                         SEQUENCE LISTING

<110>  Link Technologies Limited
 
<120>  Compounds and Methods of Use

<130>  P150018.WO.01

<150>  GB1403697.4
<151>  2014-03-03

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<221>  misc_RNA
<222>  (1)..(21)
<223>  siRNA designed to target PTENpg1 asRNA alpha variant

<400>  1
gacgaagaag aagcgagaaa c                                                 21


<210>  2
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<221>  misc_RNA
<222>  (1)..(21)
<223>  siRNA designed to target PTENpg1 asRNA alpha variant

<400>  2
guuucucgcu ucuucuucgu c                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<221>  misc_feature
<222>  (1)..(21)
<223>  single strand DNA negative control designed not to target PTENpg1
       asRNA alpha variant

<400>  3
dtttctcgct tcttcttcgt c                                                 21


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<221>  misc_feature
<222>  (1)..(21)
<223>  single strand DNA negative control designed not to target PTENpg1
       asRNA alpha variant

<400>  4
dactgacctt tggatggtgc t                                                 21


<210>  5
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<221>  misc_feature
<222>  (2)..(22)
<223>  siRNA designed to target PTENpg1 asRNA alpha variant

<400>  5
rgacgaagaa gaagcgagaa acdtt                                             25


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<221>  misc_feature
<222>  (2)..(22)
<223>  siRNA designed to target PTENpg1 asRNA alpha variant

<400>  6
rguuucucgc uucuucuucg ucdtt                                             25


